AREVA, with support from AEC Partners, signed a
Cooperative Research and Development Agreement (CRADA) with the National Cancer
Institute (NCI) in Bethesda, Maryland (USA), to develop a new treatment to fight cancer.
As part of the agreement, AREVA will provide medical quality lead-212 to the NCI for the
design of a new radiopharmaceutical drug in the near future.
Lead-212 was until today considered a very scarce radioactive element and is figuring in
promising research on treatment for certain cancers for which the current arsenal of
therapies has only limited results.
Michael McMurphy, President of AREVA Inc., offered the following comment: “AREVA is
very proud to have approved and launched this innovative project several years ago and to
contribute to progress in the field of nuclear medicine today by applying our know-how and
technology. This important project is the direct result of AREVA’s commitment to
sustainable development.”
More about
With manufacturing facilities in 43 countries and a sales network in more than 100, AREVA
offers customers reliable technological solutions for CO2-free power generation and
electricity transmission and distribution. We are the world leader in nuclear power and the
only company to cover all industrial activities in this field. Our 65,000 employees are
committed to continuous improvement on a daily basis, making sustainable development
the focal point of the group’s industrial strategy. AREVA’s businesses help meet the 21st
century’s greatest challenges: making energy available to all, protecting the planet, and
acting responsibly towards future generations.
www.areva.com
Since 1995, AEC Partners has served as strategic and financial advisor to the Healthcare
Industry. Our customer base includes most world's leading pharmaceutical, medical
devices and diagnostics companies as well as regulatory authorities, mid-size corporations,
small startups and a large number of private equity firms. Our expertise covers strategy
(organization, R&D and marketing), regulatory impact assessment, and acquisition,
strategic due diligence, mergers and acquisitions including negotiation of licensing
agreements. With offices in Paris and New York, our twenty-five strong team of seasoned
multinational professionals have consulted throughout Western Europe, US and a certain
number of developing countries.
Press Contact
Jarret Adams
Tel.: (301) 841-1695
Cell: (301) 221-5055 |
|
Laurence Pernot
Tel.: (301) 841-1694
Cell: (202) 294-8939 |
|
Patrick Bourdet
patrick.bourdet@areva.com |
|
